Article
Phenotypic and clinical implications of variants in the dihydropyrimidine dehydrogenase gene.
Biochimica et biophysica acta - 1 Apr 2016
Kuilenburg André B P van, Meijer Judith, Tanck Michael W T, Dobritzsch Doreen, Zoetekouw Lida, Dekkers Lois-Lee, Roelofsen Jeroen, Meinsma Rutger, Wymenga Machteld, Kulik Wim, Büchel Barbara, Hennekam Raoul C M, Largiadèr Carlo R
Abstract excerpt
Dihydropyrimidine dehydrogenase (DPD) is the initial and rate-limiting enzyme in the catabolism of the pyrimidine bases uracil, thymine and the antineoplastic agent 5-fluorouracil. Genetic variations in the gene encoding DPD (DPYD) have emerged as predictive risk alleles for 5FU-associated toxicity. Here we report an in-depth analysis of genetic variants in DPYD and their consequences for DPD activity and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
